123 related articles for article (PubMed ID: 23014717)
1. Completion of a truncated attenuation image from the attenuated PET emission data.
Nuyts J; Bal G; Kehren F; Fenchel M; Michel C; Watson C
IEEE Trans Med Imaging; 2013 Feb; 32(2):237-46. PubMed ID: 23014717
[TBL] [Abstract][Full Text] [Related]
2. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
Beyer T; Bockisch A; Kühl H; Martinez MJ
J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous reconstruction of activity and attenuation for PET/MR.
Salomon A; Goedicke A; Schweizer B; Aach T; Schulz V
IEEE Trans Med Imaging; 2011 Mar; 30(3):804-13. PubMed ID: 21118768
[TBL] [Abstract][Full Text] [Related]
4. The effect of limited MR field of view in MR/PET attenuation correction.
Delso G; Martinez-Möller A; Bundschuh RA; Nekolla SG; Ziegler SI
Med Phys; 2010 Jun; 37(6):2804-12. PubMed ID: 20632591
[TBL] [Abstract][Full Text] [Related]
5. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG
J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
[TBL] [Abstract][Full Text] [Related]
6. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners.
Kinahan PE; Hasegawa BH; Beyer T
Semin Nucl Med; 2003 Jul; 33(3):166-79. PubMed ID: 12931319
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction.
Nagarajah J; Dannat T; Hartung V; Bockisch A; Rosenbaum-Krumme S
Nuklearmedizin; 2012; 51(3):84-7. PubMed ID: 22366817
[TBL] [Abstract][Full Text] [Related]
8. Attenuation correction of myocardial SPECT perfusion images with low-dose CT: evaluation of the method by comparison with perfusion PET.
Fricke E; Fricke H; Weise R; Kammeier A; Hagedorn R; Lotz N; Lindner O; Tschoepe D; Burchert W
J Nucl Med; 2005 May; 46(5):736-44. PubMed ID: 15872344
[TBL] [Abstract][Full Text] [Related]
9. Truncation artifact on PET/CT: impact on measurements of activity concentration and assessment of a correction algorithm.
Mawlawi O; Erasmus JJ; Pan T; Cody DD; Campbell R; Lonn AH; Kohlmyer S; Macapinlac HA; Podoloff DA
AJR Am J Roentgenol; 2006 May; 186(5):1458-67. PubMed ID: 16632745
[TBL] [Abstract][Full Text] [Related]
10. An analytical scatter correction for singles-mode transmission data in PET.
Vandervoort E; Sossi V
IEEE Trans Med Imaging; 2008 Mar; 27(3):402-12. PubMed ID: 18334435
[TBL] [Abstract][Full Text] [Related]
11. Improved attenuation correction via appropriate selection of respiratory-correlated PET data.
Daouk J; Fin L; Bailly P; Meyer ME
Comput Methods Programs Biomed; 2008 Oct; 92(1):90-8. PubMed ID: 18676054
[TBL] [Abstract][Full Text] [Related]
12. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
Li M; Wu N; Liu Y; Zheng R; Liang Y; Zhang W; Zhao P
Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421
[TBL] [Abstract][Full Text] [Related]
13. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
[TBL] [Abstract][Full Text] [Related]
14. Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction.
Eiber M; Souvatzoglou M; Pickhard A; Loeffelbein DJ; Knopf A; Holzapfel K; Martinez-Möller A; Nekolla SG; Scherer EQ; Schwaiger M; Rummeny EJ; Beer AJ
Eur J Radiol; 2012 Oct; 81(10):2658-65. PubMed ID: 22078793
[TBL] [Abstract][Full Text] [Related]
15. Attenuation correction of PET images with respiration-averaged CT images in PET/CT.
Pan T; Mawlawi O; Nehmeh SA; Erdi YE; Luo D; Liu HH; Castillo R; Mohan R; Liao Z; Macapinlac HA
J Nucl Med; 2005 Sep; 46(9):1481-7. PubMed ID: 16157531
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides.
Ruangma A; Bai B; Lewis JS; Sun X; Welch MJ; Leahy R; Laforest R
Nucl Med Biol; 2006 Feb; 33(2):217-26. PubMed ID: 16546676
[TBL] [Abstract][Full Text] [Related]
18. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
[TBL] [Abstract][Full Text] [Related]
19. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
[TBL] [Abstract][Full Text] [Related]
20. Whole-body simultaneous positron emission tomography (PET)-MR: optimization and adaptation of MRI sequences.
Fowler KJ; McConathy J; Narra VR
J Magn Reson Imaging; 2014 Feb; 39(2):259-68. PubMed ID: 24436150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
